| Literature DB >> 35572157 |
Serdar Ongan1, Ismet Gocer2, Ayse Ongan3.
Abstract
This study investigates the impacts of pandemic-induced economic policy uncertainties (PIEPU) on the S&P500, Nasdaq-100, and Dow Jones indexes (stock returns). To this aim, for the first time, newly created IDEMV (the Infectious Disease Equity Market Volatility index (henceforth, PIEPU index) is used. The Autoregressive Distributed Lag (ARDL) model and the Toda and Yamamoto (Journal of Econometrics, 1995, 66, pp. 225-250) causality test are applied for the 2009-2020 period. Empirical findings indicate that rises in the PIEPU index lead to falls of only the S&P500 and Dow Jones indexes. Corporations in the tech-heavy Nasdaq100 index do not negatively respond to rises in the PIEPU index. Additionally, the negative impacts of the rises in the specifically COVID-19 based-constructed PIEPU (DCOVPIEPU) index on the S&P500 and Dow Jones indexes are higher than the negative impacts of the general PIEPU index. This can be interpreted to mean that the larger the magnitude and spread rate of a pandemic, the larger the negative impacts on stock returns. In the sample period of this study, COVID-19 is the largest and most destructive pandemic compared to H1N1 and Ebola.Entities:
Keywords: COVID‐19; Infectious Disease IDEMV Index; stock exchanges
Year: 2022 PMID: 35572157 PMCID: PMC9088423 DOI: 10.1002/pa.2799
Source DB: PubMed Journal: J Public Aff ISSN: 1472-3891
Unit root test results
| ADF | PP | KPSS | |
|---|---|---|---|
|
| −11.66*** (0.00) | −61.90*** (0.00) | 0.03*** |
|
| −12.55*** (0.00) | −61.02*** (0.00) | 0.03*** |
|
| −11.62*** (0.00) | −61.89*** (0.00) | 0.03*** |
|
| −2.52(0.10) | −1.50 (0.12) | 678.87 |
|
| −12.73*** (0.00) | −206.01*** (0.00) | 0.17*** |
|
| −2.34 (0.15) | −1.67 (0.12) | 725.24 |
|
| −12.62*** (0.00) | −72.91*** (0.00) | 0.01*** |
Note: Critical values in the KPSS test are 0.73, 0.46, and 0.34 for 1%, 5%, and 10%, respectively. p‐values are in the parenthesis. First differences. *** denotes significance at 1% level. ADF: Augmented Dickey Fuller Test. PP: Phillips‐Perron Test. KPSS: Kwiatkowski‐Phillips‐Schmidt ‐Shin Test.
Cointegration test results
| (1) S&P 500 | (2) Dow Jones | (3) Nasdaq‐100 | |
|---|---|---|---|
|
| 9.14** | 11.05*** | 10.26*** |
|
| 8.48*** | 10.14*** | 7.17** |
| Critical values | |||
| 10% | 5% | 1% | |
| Lower bounds (for | 5.59 | 6.56 | 8.74 |
| Upper bounds (for | 6.26 | 7.30 | 9.63 |
| Lower bounds (for | 4.19 | 4.87 | 6.34 |
| Upper bounds (for | 5.06 | 5.85 | 7.52 |
Note: The values are F‐statistics. k is the number of independent variables. *** and ** denote significances at 1% and 5% levels.
Lon‐run and short‐run ARDL model results (Model 1: Without specific COVID‐19 effect)
| Unnormalized long‐run | Normalized long‐run | Short‐run | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| (1) | (2) | (3) | (1) | (2) | (3) | (1) | (2) | (3) | ||
| S&P500 | Dow Jones | Nasdaq‐100 | S&P500 | Dow Jones | Nasdaq‐100 | S&P 500 | Dow Jones | Nasdaq‐100 | ||
|
| 0.85*** (0.00) | 0.85*** (0.00) | 0.87*** (0.00) | — | — | — |
| −0.12*** (0.00) | −0.13*** (0.00) | −0.11*** (0.00) |
|
| 0.19*** (0.00) | 0.22*** (0.00) | 0.16*** (0.00) | — | — | — |
| 0.07*** (0.00) | 0.09*** (0.00) | 0.05*** (0.00) |
|
| −0.07*** (0.00) | −0.07*** (0.00) | −0.05*** (0.00) | — | — | — |
| — | 0.01*** (0.00) | — |
|
| — | −0.01 (0.30) | — | — | — | — |
| — | — | — |
|
| 0.007 (0.44) | 0.007 (0.47) | 0.0001 (0.31) | −0.018* (0.07) | −0.026***(0.00) | −0.013 (0.19) |
| 0.007 (0.41) | 0.007 (0.45) | 0.0001 (0.28) |
|
| −0.008 (0.43) | −0.008 (0.40) | −0.009 (0.41) | — | — | — |
| 0.0002** (0.02) | 0.004*** (0.00) | 0.0002* (0.06) |
|
| −0.004 (0.68) | −0.006 (0.49) | −0.006 (0.57) | — | — | — |
| 0.002** (0.03) | 0.003*** (0.00) | 0.0001 (0.13) |
|
| −0.0002**(0.04) | −0.0002**(0.03) | −0.0001 (0.15) | — | — | — |
| 0.0001 (0.20) | ‐ | |
|
| — | −0.0001 (0.22) | — | — | — | — |
| −0.01*** (0.00) | −0.01*** (0.00) | −0.01*** (0.000) |
|
| 0.09*** (0.00) | 0.14*** (0.00) | 0.11*** (0.00) | 6.94*** (0.00) | 9.18*** (0.00) | 7.59*** (0.00) |
| 0.09*** (0.00) | 0.14*** (0.00) | 0.11*** (0.00) |
|
| 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 |
| 0.33 | 0.38 | 0.26 |
|
| 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 |
| 0.30 | 0.35 | 0.23 |
|
| 359509.2 (0.00) | 270077.8 (0.00) | 508615.1 (0.00) | 35950.2 (0.00) | 27077.8 (0.00) | 508615.1 (0.00) |
| 14.01 (0.00) | 12.80 (0.00) | 11.00 (0.00) |
|
| 2.00 | 1.99 | 1.99 | 2.00 | 1.99 | 1.99 |
| 2.00 | 1.99 | 1.99 |
|
| 0.57 (0.75) | 0.75 (0.69) | 0.07 (0.96) | 0.57 (0.75) | 0.75 (0.69) | 0.07 (0.96) |
| 0.57 (0.75) | 0.75 (0.69) | 0.07 (0.96) |
Note: p‐values are in the parenthesis. *, **, and *** denote significances at 10%, 5%, and 1% levels.
Lon‐run and short‐run ARDL model results (Model 2: With specific COVID‐19 effect)
| Unnormalized long‐run | Normalized long‐run | Short‐run | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| (1) | (2) | (3) | (1) | (2) | (3) | (1) | ((2) | (3) | ||
| S&P500 | Dow Jones | Nasdaq‐100 | S&P500 | Dow Jones | Nasdaq‐100 | S&P500 | Dow Jones | Nasdaq‐100 | ||
|
| 0.85*** (0.00) | 0.85*** (0.00) | 0.87*** (0.00) | — | — | — |
| −0.13*** (0.00) | −0.13*** (0.00) | −0.11*** (0.00) |
|
| 0.20*** (0.00) | 0.22*** (0.00) | 0.16*** (0.00) | — | — | — |
| 0.06** (0.00) | 0.08*** (0.00) | 0.04*** (0.00) |
|
| −0.06*** (0.00) | −0.08*** (0.00) | −0.04*** (0.00) | — | — | — |
| — | — | — |
|
| 0.0001 (0.24) | 0.0001 (0.30) | 0.0001 (0.35) | 0.008 (0.27) | 0.006 (0.32) | 0.007 (0.37) |
| — | — | — |
|
| −0.006***(0.00) | −0.0008*** (0.00) | −0.0003 (0.12) | −0.04*** (0.00) | −0.05*** (0.00) | −0.02 (0.12) |
| −0.01*** (0.00) | −0.01*** (0.00) | −0.01*** (0.00) |
|
| 0.10*** (0.00) | 0.14*** (0.00) | 0.10*** (0.00) | 6.88*** (0.00) | 9.11*** (0.00) | 7.55*** (0.00) |
| 0.10*** (0.00) | 0.14*** (0.00) | 0.10*** (0.00) |
|
| 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 |
| 0.34 | 0.40 | 0.25 |
|
| 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 |
| 0.33 | 0.38 | 0.24 |
|
| 48096.9 (0.00) | 451971.9 (0.00) | 678180.8 | 480296.9 (0.00) | 451971.9 (0.00) | 678180.8 |
| 25.49 (0.00) | 29.78 (0.00) | 18.79 (0.00) |
|
| 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 |
| 1.99 | 1.99 | 1.99 |
|
| 0.08 (0.95) | 1.59 (0.45) | 0.09 (0.95) | 0.08 (0.95) | 1.59 (0.45) | 0.09 (0.95) |
| 0.08 (0.95) | 1.59 (0.45) | 0.09 (0.95) |
Note: p‐values are in the parenthesis. *, **, and *** denote significances at 10%, 5%, and 1% levels.
Toda and Yamamoto (1995) causality test results
|
|
|
|
| |
|---|---|---|---|---|
|
|
14 [LR, FPE, AIC] | 1 | 13.77 | 0.54 |
|
|
10 [LR, FPE, AIC] | 1 | 26.92*** | 0.00 |
|
|
16 [FPE, AIC] | 1 | 13.49 | 0.70 |
|
|
10 [LR, FPE, AIC, HQ] | 1 | 37.07*** | 0.00 |
|
|
9 [LR, FPE, AIC, HQ] | 1 | 8.16 | 0.61 |
|
|
5 [LR, FPE, AIC, HQ] | 1 | 4.95 | 0.54 |
Abbreviations: AIC, Akaike information criterion; FPE, final prediction error; HQ: Hannan‐Quinn information criterion; LR, sequential modified LR test statistic (each test at 5% level).
Descriptive statistics
| Log(PIEPU) | Log(S&P500) | Log(DOW Jones) | Log(Nasdaq‐100) | |
|---|---|---|---|---|
| Mean | 1.98 | 7.49 | 9.69 | 8.33 |
| Median | 0.00 | 7.57 | 9.72 | 8.40 |
| Maximum | 8.83 | 8.13 | 10.29 | 9.19 |
| Minimum | 0.00 | 6.52 | 8.79 | 7.15 |
| Std. Dev. | 2.31 | 0.36 | 0.34 | 0.48 |
| Skewness | 0.58 | −0.30 | −0.18 | −0.17 |
| Kurtosis | 2.04 | 2.06 | 2.16 | 2.01 |
| Jarque‐Bera | 270.3 | 147.3 | 99.1 | 130.8 |
| Probability | 0.00 | 0.00 | 0.00 | 0.00 |
| Sum | 5657.63 | 21435.65 | 27733.01 | 23840.46 |
| Sum Sq. Dev. | 15317.74 | 380.8993 | 335.535 | 648.8037 |
| Observations | 2862 | 2862 | 2862 | 2862 |
Note: The differences of max. and min. values and standard deviations of the variables are low. The number of observations is enough.
FIGURE A1CUSUM charts of Model 1 (without specific COVID‐19 effect)
FIGURE A2CUSUM charts of Model 2 (with specific COVID‐19 effect)